Profilo
Javad Shahidi worked as Vice President-Global Research & Development at Daiichi Sankyo, Inc. from 2019 to 2022.
He also worked as Chief Medical Officer at Centessa Pharmaceuticals Plc in 2022.
Prior to his professional experience, he earned a graduate degree from McGill University and a doctorate degree from Shahid Beheshti University of Medical Sciences.
Precedenti posizioni note di Javad Shahidi
| Società | Posizione | Fine |
|---|---|---|
| CENTESSA PHARMACEUTICALS PLC | Direttore Tecnico/Scientifico/R&S | 14/10/2022 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Direttore Tecnico/Scientifico/R&S | 01/03/2022 |
Formazione di Javad Shahidi
| McGill University | Graduate Degree |
| Shahid Beheshti University of Medical Sciences | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | Health Technology |
- Borsa valori
- Insiders
- Javad Shahidi
